Hepion Pharmaceuticals raises $3.06 million in private placement of 61,100,000 shares at $0.05 each
HEPA•Private placement terms
Hepion Pharmaceuticals priced a private placement of 61,100,000 common shares at $0.05 each for $3.06 million gross proceeds.
The deal included warrants to buy 61,100,000 shares at $0.06, exercisable for five years from issuance.
Closing and offering structure
The offering closed Aug. 3, 2026.
Securities were sold in an unregistered offering under Section 4(a)(2) and/or Rule 506(b) of Regulation D.
